Adjusted for PM2.5. Infant (<12 months n/a n/a n/a n/a n/a No CRF age) recommended. Life expectancy lost n/a n/a n/a n/a n/a No CRF (years of life lost) recommended. Morbidity Incidence of chronic n/a n/a n/a n/a n/a No CRF obstructive recommended. pulmonary disease (COPD) or chronic bronchitis Incidence of asthma Ever had wheezing: n/a n/a 2.8% (0.1-5.6%) per n/a No CRF Protective effect in 1 ppb recommended. single and () pollutant models () No effect in with PM, NO2, SO2 Age: Non-asthmatic Australian 6-cities and CO. males 27+ years. study (). Annual average Ever had asthma: ozone. Study by McDonnell Protective effect in et al () may be used single and in a sensitivity pollutant models analysis. with PM, NO2, SO2 and CO. () Six cities – Adelaide, Brisbane, Canberra,
Adjusted for PM2.5. Infant (<12 months age) n/a n/a n/a n/a n/a No CRF recommended. Life expectancy lost (years of life lost) n/a n/a n/a n/a n/a No CRF recommended. Morbidity Incidence of chronic obstructive pulmonary disease (COPD) or chronic bronchitis n/a n/a n/a n/a n/a No CRF recommended. Incidence of asthma Ever had wheezing: Protective effect in single and models with PM, NO2, SO2 and CO. Ever had asthma: Protective effect in single and models with PM, NO2, SO2 and CO. () Six cities – Adelaide, Brisbane, Canberra, n/a n/a 2.8% (0.1-5.6%) per 1 ppb () () Age: Non-asthmatic males 27+ years. Annual average ozone. n/a No CRF recommended. No effect in Australian 6-cities study (). Study by McDonnell et al () may be used in a sensitivity analysis. pollutant pollutant
health-report.docx